DE69322872T2 - Vakzine gegen immunodefizienz-virus der katze (kiv) - Google Patents

Vakzine gegen immunodefizienz-virus der katze (kiv)

Info

Publication number
DE69322872T2
DE69322872T2 DE69322872T DE69322872T DE69322872T2 DE 69322872 T2 DE69322872 T2 DE 69322872T2 DE 69322872 T DE69322872 T DE 69322872T DE 69322872 T DE69322872 T DE 69322872T DE 69322872 T2 DE69322872 T2 DE 69322872T2
Authority
DE
Germany
Prior art keywords
kiv
cat
immunodeficiency virus
vaccine against
fiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69322872T
Other languages
English (en)
Other versions
DE69322872D1 (de
Inventor
Michael Francis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet Inc
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Application granted granted Critical
Publication of DE69322872D1 publication Critical patent/DE69322872D1/de
Publication of DE69322872T2 publication Critical patent/DE69322872T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE69322872T 1992-09-21 1993-09-20 Vakzine gegen immunodefizienz-virus der katze (kiv) Expired - Lifetime DE69322872T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929219936A GB9219936D0 (en) 1992-09-21 1992-09-21 Vaccines
PCT/GB1993/001974 WO1994006471A1 (en) 1992-09-21 1993-09-20 Anti-feline immunodeficiency virus (fiv) vaccines

Publications (2)

Publication Number Publication Date
DE69322872D1 DE69322872D1 (de) 1999-02-11
DE69322872T2 true DE69322872T2 (de) 1999-05-27

Family

ID=10722245

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69322872T Expired - Lifetime DE69322872T2 (de) 1992-09-21 1993-09-20 Vakzine gegen immunodefizienz-virus der katze (kiv)

Country Status (11)

Country Link
EP (1) EP0661999B1 (de)
JP (1) JP3604384B2 (de)
AT (1) ATE175119T1 (de)
AU (1) AU4826493A (de)
DE (1) DE69322872T2 (de)
DK (1) DK0661999T3 (de)
ES (1) ES2127294T3 (de)
GB (1) GB9219936D0 (de)
GR (1) GR3029264T3 (de)
WO (1) WO1994006471A1 (de)
ZA (1) ZA936970B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833993A (en) * 1994-04-29 1998-11-10 Pharmacia & Upjohn Company Feline immunodeficiency virus vaccine
IT1276509B1 (it) * 1995-03-31 1997-10-31 Istituto Superiore Della Sanit Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
US5849303A (en) * 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
BR9610343A (pt) * 1995-08-25 1999-12-21 Univ Florida Vacinas de subtipos múltiplos para fiv
FR2769916B1 (fr) * 1997-10-17 2000-12-01 Centre Nat Rech Scient Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
FR2771011B1 (fr) 1997-11-17 2000-01-28 Hippocampe Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
GB9827077D0 (en) 1998-12-09 1999-02-03 Expro North Sea Ltd Improvements in or relating to well fluid sampling
AU6683400A (en) * 1999-07-08 2001-01-30 Mologen Forschungs-, Entwicklungs- Und Vertriebs Gmbh Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat
FR2828687B1 (fr) * 2001-08-17 2003-12-12 Hippocampe Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
FR2828686B1 (fr) * 2001-08-17 2003-12-12 Hippocampe Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
AU2004273076B2 (en) 2003-09-11 2008-02-14 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP4717009B2 (ja) 2003-12-18 2011-07-06 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスの検出のための方法と装置
AU2005215629B2 (en) * 2004-02-19 2009-01-29 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2006011920A1 (en) 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
US7285278B2 (en) 2004-06-30 2007-10-23 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US8809004B2 (en) 2010-04-02 2014-08-19 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2669338A1 (fr) * 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US6228608B1 (en) * 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
AU667669B2 (en) * 1991-06-14 1996-04-04 Idexx Laboratories, Inc. Detection of mammalian immunodeficiency viruses
WO1993001304A1 (en) * 1991-07-10 1993-01-21 Synbiotics Corporation Synthetic peptides related to fiv-env proteins

Also Published As

Publication number Publication date
ATE175119T1 (de) 1999-01-15
ZA936970B (en) 1994-08-29
JP3604384B2 (ja) 2004-12-22
AU4826493A (en) 1994-04-12
WO1994006471A1 (en) 1994-03-31
GB9219936D0 (en) 1992-11-04
JPH08504090A (ja) 1996-05-07
EP0661999A1 (de) 1995-07-12
GR3029264T3 (en) 1999-05-28
ES2127294T3 (es) 1999-04-16
DK0661999T3 (da) 1999-08-30
EP0661999B1 (de) 1998-12-30
DE69322872D1 (de) 1999-02-11

Similar Documents

Publication Publication Date Title
DE69322872D1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
DE69636487D1 (de) Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
ATE430200T1 (de) Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
ES2075040T3 (es) 2',3'-dideoxi-2',2'-difluoronucleosidos.
ATE241014T2 (de) Hiv-2 varianten
NO912825L (no) Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper.
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
HUP0000432A2 (hu) Inzulin C-peptidek
HUP9901688A2 (hu) A diabétesz kezelésére szolgáló, humán hősokk protein 60-ból származó új peptidek, készítmények, eljárások és kitek
SE9101838D0 (sv) Novel peptides and their use
PT996726E (pt) Proteina de membrana de celulas t (tirc7) peptidos e anticorpos dela derivados e suas utilizacoes
PT81345B (pt) Processo para a preparacao de novos peptideos activos sobre o sistema nervoso central com accao sobre o sistema colinergico, e de composicoes farmaceuticas contendo estes compostos
ATE154244T1 (de) Induzierung eines schutzes gegen virale infektionen
NO854903L (no) Peptidvaksine eller -diagnosemiddel, samt polypeptid for slik anvendelse.
CA2143187A1 (en) Anti-feline immunodeficiency virus (fiv) vaccines
DE69130675T2 (de) Klonierung und expression eines rhoptry-assoziierten proteins aus p. falciparum
ES2059801T3 (es) Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
ATE234861T1 (de) Influenzaimpfstoff, der als sinergistischer zusatzmittel influenzavirusinnenkörper enthält
RU96116005A (ru) Штамм hominis immunodeficiti virus (hiv-i) вич-i/россия/гм-12-95 (ru1295) субтипа в для диагностических и вакцинных препаратов
FI902814A0 (fi) Proteiner, vaccin och nukleinsyror.
BR0016740A (pt) Antìgenos de esporozoìto de cryptosporidium
SE9202318D0 (sv) Nya peptider, diagnostiska antigen, anvaendning daerav, vacciner och medikamenter
AR036104A1 (es) Un receptor acoplado a la proteina g, gave3

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SCHERING PLOUGH ANIMAL HEALTH CORP., UNION, N.J.,